日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma

Zanidatamab联合Tislelizumab和化疗一线治疗HER2阳性胃/胃食管交界处腺癌的Ib/II期研究

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-4295
Lee, Keun-Wook; Bai, Li-Yuan; Jung, Minkyu; Ying, Jieer; Im, Young-Hyuck; Oh, Do-Youn; Cho, Jae Yong; Oh, Sang Cheul; Chao, Yee; Kim, Jin Won; Chen, Ye; Li, Vincent; Chen, Shengnan; Kang, Yoon-Koo
肿瘤
肿瘤免疫
HER2
发表日期：2026
文献求助 收藏

Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer

腹腔内注射纳武利尤单抗治疗晚期胃肠道或胰胆管癌患者的恶性腹水

期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-025-02930-y
Wang, Hsiu-Tzu; Yu, Yung-Luen; Lo, Wen-Jyi; Lin, Mei-Chen; Chu, Chien-Lun; Chen, Chia-Yu; Wang, Sing-Ting; Chiu, Chang-Fang; Bai, En-Jia; Bai, Li-Yuan
肿瘤
胆管癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summary

纳武利尤单抗联合化疗治疗亚洲晚期或复发性胃癌或胃食管交界处癌患者（ATTRACTION-4 研究）：简明语言摘要

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2622806
Chen, Li-Tzong; Kang, Yoon-Koo; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Chung, Ik-Joo; Yamaguchi, Kensei; Kato, Ken; Sym, Sun Jin; Kadowaki, Shigenori; Tsuji, Kunihiro; Chen, Jen-Shi; Bai, Li-Yuan; Oh, Sung-Yong; Choda, Yasuhiro; Yasui, Hisateru; Takeuchi, Kentaro; Hirashima, Yoshinori; Hagihara, Shunsuke; Boku, Narikazu
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Circulating miRNAs as potentially predictive biomarkers for chemoimmunotherapy in advanced biliary tract cancer: a post-hoc analysis of the phase II T1219 study.

循环 miRNA 作为晚期胆道癌化疗免疫疗法的潜在预测生物标志物：II 期 T1219 研究的事后分析

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-01099-x
Chiang Nai-Jung, Tang Cheng-Yu, Bai Li-Yuan, Chang Po-Chang, Chen Wei-Ming, Kang Shih-Ting, Chen San-Chi, Chen Ming-Huang, Hsieh Jason Chia-Hsun
肿瘤
miRNA
发表日期：2025
文献求助 收藏

Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors

口服节拍式吉西他滨（D07001）治疗晚期实体瘤患者的I期研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf051
Chiang, Nai-Jung; Lee, Jih-Hsiang; Chen, Ming-Huang; Chao, Yee; Su, Wu-Chou; Bai, Li-Yuan; Wu, Shang-Yin; Hsu, Chih-Hung; Shan, Yan-Shen; Li, Chung-Pin; Chen, Shang-Hung; Chung, Wei-Pang; Hao, Wei-Hua; Chen, Li-Tzong; Lin, Chia-Chi
发表日期：2025
文献求助 收藏

Real-World Study of Lanreotide Autogel in Routine Practice in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Hong Kong and Taiwan

香港和台湾地区在常规临床实践中应用兰瑞肽缓释凝胶治疗胃肠胰神经内分泌肿瘤（GEP-NETs）患者的真实世界研究

期刊:Oncology and Therapy
影响因子:3.2
doi:10.1007/s40487-024-00302-6
Chen, Jen-Shi; Bai, Li-Yuan; Cheng, Hsiao-Hsiang; Chan, Stephen Lam; Zou, Ji-Yan; Shi, Xiaofeng; Houchard, Aude; Truong-Thanh, Xuan-Mai; Chen, Ming-Huang
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Novel Insights into PGM2L1 as a Prognostic Biomarker in Cholangiocarcinoma: Implications for Metabolic Reprogramming and Tumor Microenvironment Modulation

PGM2L1作为胆管癌预后生物标志物的新见解：对代谢重编程和肿瘤微环境调控的意义

期刊:International Journal of Medical Sciences
影响因子:3.2
doi:10.7150/ijms.106566
Wu, Guo-Wei; Hsieh, Yi-Hsien; Chien, Yi-Chung; Bai, Li-Yuan; Yu, Yung-Luen
肿瘤
肿瘤免疫
信号转导
代谢
代谢重编程
胆管癌
肿瘤微环境
发表日期：2025
文献求助 收藏

Aberrant ALPP Expression Serves as a Prognostic Biomarker and Facilitates Cholangiocarcinoma Progression through Immune Evasion and PI3K-Akt Signaling Activation

异常的ALPP表达可作为预后生物标志物，并通过免疫逃逸和PI3K-Akt信号通路激活促进胆管癌进展。

期刊:International Journal of Medical Sciences
影响因子:3.2
doi:10.7150/ijms.116260
Wu, Guo-Wei; Chien, Yi-Chung; Bai, Li-Yuan; Yu, Yung-Luen
肿瘤
肿瘤免疫
信号转导
胆管癌
LPP
ALPP
免疫/内分泌
发表日期：2025
文献求助 收藏

A synthetic molecule targeting STAT3 against human oral squamous cell carcinoma cells.

一种靶向 STAT3 的合成分子，用于对抗人类口腔鳞状细胞癌细胞

期刊:International Journal of Medical Sciences
影响因子:3.2
doi:10.7150/ijms.105200
Bai Li-Yuan, Dokla Eman M E, Chu Po-Chen, Feng Chia-Hsien, Hu Jing-Lan, Wang Liang-Jun, Weng Jing-Ru
细胞生物学
Human
肿瘤免疫
发表日期：2025
文献求助 收藏

Nanoliposomal Irinotecan in Combination With 5-Fluorouracil and Leucovorin for Advanced Head and Neck and Esophageal Squamous Cell Carcinoma After Prior Platinum-Based Chemotherapy or Chemoradiotherapy: A Multicenter Phase II Trial

纳米脂质体伊立替康联合5-氟尿嘧啶和亚叶酸钙治疗既往接受过铂类化疗或放化疗的晚期头颈部和食管鳞状细胞癌：一项多中心II期试验

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71307
Yang, Muh-Hwa; Wu, Shang-Yin; Ho, I-Wei; Chiang, Nai-Jung; Hsaio, Chin-Fu; Lin, Chen-Yuan; Lien, Ming-Yu; Chang, Peter Mu-Hsin; Chen, Jia-Hong; Hsieh, Ching-Yun; Hong, Ruey-Long; Lee, Chao-Tung; Chen, Li-Tzong; Liu, Tsang-Wu; Chiu, Chang-Fang; Bai, Li-Yuan
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏